Company intelligence / Profile preview

Veto-Pharma

Palaiseau, Île-de-France, France

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Véto-pharma is a specialized pharmaceutical company dedicated to honey bee health and the sustainability of the beekeeping industry. Based in France, the company develops and manufactures a range of veterinary medicines and diagnostic tools, with a primary focus on controlling the Varroa destructor mite. Their flagship products, such as Apivar and Apistan, are global standards in honey bee parasite management. In addition to pest control, Véto-pharma offers nutritional supplements and monitoring devices to support colony vitality. The company operates its own GMP-compliant manufacturing facility and distributes its products to over 35 countries worldwide.

Therapeutic areas: Other
Modalities: Small moleculeDevice
Industry: Veterinary

Beyond the preview

Go deeper on Veto-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veto-Pharma.

Explore the full profile